about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorBraking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functionsHub and switches: endocannabinoid signalling in midbrain dopamine neuronsRevealing the paradox of drug reward in human evolutionLegal highs: staying on top of the flood of novel psychoactive substancesThe role of the GABA system in amphetamine-type stimulant use disordersIllicit dopamine transients: reconciling actions of abused drugsKir3 channel signaling complexes: focus on opioid receptor signalingStriatal signal transduction and drug addictionDrug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulationOrganization of GABAergic synaptic circuits in the rat ventral tegmental areaBeyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.Proximity of Substantia Nigra Microstimulation to Putative GABAergic Neurons Predicts Modulation of Human Reinforcement LearningBiological substrates of addiction.Neural bases for addictive properties of benzodiazepines.Electrophysiological evidence for functionally distinct neuronal populations in the human substantia nigra.MSI-1436 reduces acute food intake without affecting dopamine transporter activity.Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodelingOptical suppression of drug-evoked phasic dopamine releaseProtein kinases and addiction.Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.Extrasynaptic GABAA receptors in the nucleus accumbens are necessary for alcohol drinking.Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine.PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmissionRapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery.Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice.GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent MannermGluR-Dependent Synaptic Plasticity in Drug-SeekingRASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release.Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement.Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABA(A) receptors.G Protein-Gated Inwardly Rectifying Potassium Channel Subunit 3 Knock-Out Mice Show Enhanced Ethanol RewardReinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys.Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.Hyposensitivity to gamma-aminobutyric acid in the ventral tegmental area during alcohol withdrawal: reversal by histone deacetylase inhibitorsAddictive drugs modulate GIRK-channel signaling by regulating RGS proteinsPeroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuseThe biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
P2860
Q22241964-608135DD-11E0-47B4-B78F-0D57629DB00FQ24603596-465E0312-DF9B-4EDD-9D51-6BD3B4E7098CQ24623244-1B6EA2EC-6345-49BD-BB01-D14BF64BF559Q24646551-C0009D33-1E4E-4C4D-860E-FC3FA5E5E6F6Q26799231-139F00B7-D938-46DC-BA2E-1819B6E50761Q26824348-DD0DA200-AD61-4E2A-AA23-DA2BA67D960CQ26997102-B4727283-C7C0-4524-9A00-8E27BAF523F5Q27006957-A694298A-168A-4CA2-A702-51954E88A1C0Q28392093-E3C500E3-EF56-4D4F-ABB6-F37C5840E330Q28476676-82296C18-5E09-4F8F-A2D3-E0D5D8BCB593Q28484279-53122999-CFB9-48E1-B88F-789F097ED35AQ30466591-FC8B452E-FAC7-468C-BE99-6991DE52CC15Q30580823-45736D52-F025-4ABB-A3B3-359BC76A4159Q33650033-750A4BB0-E62E-45BF-B469-98C53BB7EB84Q33835356-A692BB37-D06A-41A7-94A1-D406A7EC4C4BQ33855956-3349DEE6-8049-47C8-B4CA-04BEE9B47F9AQ34153959-CD0DE8AE-BEB3-46C5-8FC9-4EEAC5FBFF9AQ34155566-78B26D11-814C-40B9-B4A6-A63281CE2194Q34166000-1DC7BE06-0E7A-4696-A134-9466F29F6903Q34198509-003585E9-396D-4B10-8A89-EFB54689BE35Q34630295-8B83F75D-F9AD-4DAC-9980-1BC778ACC29CQ34643934-A799DF63-DF21-4DA4-8E67-2D6127EBC54BQ34720684-102B38E4-AF38-466E-BCA5-E96C6DE7C2DBQ34961709-B60E9203-DA37-4BA1-BC2E-A1F51731EF34Q35089395-F4ACF5E0-246F-4CAA-B230-4292A4C45C8FQ35174410-E22712A1-9D9D-4BDB-B73A-7173A8B4E5B1Q35179014-928B776D-861D-4C99-8A0D-DE2EA487198FQ35572537-16C4BF76-676C-4556-BB43-A055CEE2069FQ36190373-F10088FA-FD25-4240-9117-A6F438C1C515Q36485264-2E397251-EE98-464C-AE8E-2245C787E519Q36498162-E0161A89-0312-4ED2-9318-F5C25985D71EQ36533714-A379F88A-9446-458D-B65C-DBCB0F68ABF2Q36763979-B81A892A-76F4-40D8-BD8A-5781C8E8F308Q36775238-BB5AC0FD-1ABC-4E33-8B2A-694CFBE63C3DQ37014115-A492F9E6-0353-40AC-9647-C3FFEF27F527Q37030234-9DD84296-CB7D-48BE-9541-A78F6FFB4940Q37268383-FD87A51A-2F19-439F-A828-1027AFEC4C37Q37304747-70F4C518-A2A3-43F0-925A-71265DA2857CQ37316522-0F2426F4-22CB-434E-90EA-F16F5995A458Q37397573-9D60F009-31E3-4000-88E5-80459533E8D8
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The mechanistic classification of addictive drugs
@ast
The mechanistic classification of addictive drugs
@en
The mechanistic classification of addictive drugs
@en-gb
The mechanistic classification of addictive drugs
@nl
type
label
The mechanistic classification of addictive drugs
@ast
The mechanistic classification of addictive drugs
@en
The mechanistic classification of addictive drugs
@en-gb
The mechanistic classification of addictive drugs
@nl
altLabel
The Mechanistic Classification of Addictive Drugs
@en
prefLabel
The mechanistic classification of addictive drugs
@ast
The mechanistic classification of addictive drugs
@en
The mechanistic classification of addictive drugs
@en-gb
The mechanistic classification of addictive drugs
@nl
P2860
P3181
P1433
P1476
The mechanistic classification of addictive drugs
@en
P2093
Christian Lüscher
P2860
P3181
P356
10.1371/JOURNAL.PMED.0030437
P407
P5008
P577
2006-11-01T00:00:00Z